Improvement in Baroreflex Sensitivity in OSAS
The recruitment status of this study is unknown because the information has not been verified recently.
Verified May 2005 by Nagoya University.
Recruitment status was Recruiting
Recruitment status was Recruiting
Sponsor:
Nagoya University
Information provided by:
Nagoya University
ClinicalTrials.gov Identifier:
NCT00284037
First received: January 27, 2006
Last updated: NA
Last verified: May 2005
History: No changes posted
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Individuals with obstructive sleep apnea syndrome (OSAS) are at high risk for cardiovascular morbidity and mortality. The effect of long-term nocturnal therapy with continuous positive airway pressure (CPAP) on daytime baroreflex sensitivity (BRS), a predictor of cardiac death, was investigated in OSAS patients.
| Condition | Intervention |
|---|---|
|
Obstructive Sleep Apnea Syndrome |
Device: continuous positive airway pressure therapy |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Efficacy Study Intervention Model: Parallel Assignment Masking: Open Label Primary Purpose: Treatment |
Resource links provided by NLM:
Further study details as provided by Nagoya University:
Eligibility| Ages Eligible for Study: | 20 Years to 70 Years |
| Genders Eligible for Study: | Both |
Criteria
Inclusion Criteria:
- obstructive sleep apnea syndrome
Exclusion Criteria:
- diabetes mellitus, chronic obstructive lung disease, coronary or valvular heart disease, congestive heart failure, renal failure, or endocrine dysfunction. Moreover, none of them were taking b-blockers, vasodilators, or inotropic agents at the time of enrollment in the study.
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00284037
Contacts
| Contact: Akiko Noda, PhD | +81-52-719-1537 | a-noda@met.nagoya-u.ac.jp |
Locations
| Japan | |
| Nagoya University of Health Sciences | Recruiting |
| Nagoya, Japan, 461-8673 | |
| Contact: Akiko Noda, PhD +81-719-1537 a-noda@met.nagoya-u.ac.jp | |
| Principal Investigator: Akiko Noda, PhD | |
Sponsors and Collaborators
Nagoya University
Investigators
| Study Chair: | Mitsuhiro Yokota, MD.PhD | Department of Cardiovascular Genome Science, Nagoya University School of Medicine, Nagoya, Aichi, Japan |
More Information
No publications provided
| ClinicalTrials.gov Identifier: | NCT00284037 History of Changes |
| Other Study ID Numbers: | NU-06-A-0003 |
| Study First Received: | January 27, 2006 |
| Last Updated: | January 27, 2006 |
| Health Authority: | Japan: Ministry of Health, Labor and Welfare |
Keywords provided by Nagoya University:
|
obstructive sleep apnea, baroreceptors |
Additional relevant MeSH terms:
|
Apnea Sleep Apnea Syndromes Sleep Apnea, Obstructive Respiration Disorders Respiratory Tract Diseases Signs and Symptoms, Respiratory |
Signs and Symptoms Sleep Disorders, Intrinsic Dyssomnias Sleep Disorders Nervous System Diseases |
ClinicalTrials.gov processed this record on June 17, 2013